MBio Diagnostics Announces Rebrand to LightDeck Diagnostics to Reflect Commitment to Its Innovative Waveguide Product Platform

MBio Diagnostics, the company taking the point-of-care anywhere with on-the-spot, central lab-quality diagnostics, announced today that it is changing its corporate name to LightDeck Diagnostics. The...

Learn More

Denver-Boulder among top U.S. life science clusters for the first time

The Denver metro area has ranked among the largest U.S. life science markets for the first time, in a new report from CBRE. The report on U.S. life sciences ranks the top clusters in the country. On t...

Learn More

Summit Biolabs Announces Strategic Collaboration to Develop and Commercialize Saliva Liquid-biopsy Tests for COVID-19 and Head & Neck Cancers

Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM...

Learn More

PharmaJet’s Needle-free System to be used in Australian Clinical COVID-19 Trial

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Stratis® Needle-free Injection System will be used to deliver a vaccine against SARS-CoV-2 in a clinical...

Learn More

Invitae completes its $1.4B acquisition of Boulder-based ArcherDX

ArcherDX had previously applied for an IPO before the public company its acquisition was announced. Learn more in the Denver Business Journal.

Learn More

Brickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...

Learn More

Westminster biotech company shares new strategy for cancer treatments.

A Westminster biotech company has a new clinical development strategy following a recent acquisition it made. TriSalus Life Sciences is an emerging immuno-oncology company that has developed technolog...

Learn More

Aspero Medical Receives $310,000 Grant for Development of Pillar™ Micro-Textured Gastrointestinal Endoscopic Balloon Overtube

Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line. Aspero Medical, a medical device startup focused on developin...

Learn More

ARCA Biopharma files application for Covid-19 drug treatment

The company has a drug in its arsenal that it believes could be effective in the treatment of Covid-19 patients. Find out more in the Denver Business Journal.

Learn More

Ampio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients

Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scaleAmpion-treated patients showed greater improvement compared to patients trea...

Learn More